Total androgen blockade for prostate cancer

Acta Urologica Japonica

Volumn 43, Issue 3, 1997, Pages 197-201

  Kagebayashi, Yoriaki ^a   Ozono, Seiichiro ^a   Takashima, Kenji ^a   Yoshikawa, Motohiro ^a   Hayashi, Yoshiki ^a   Kaneko, Yoshiteru ^a   Maruyama, Yoshio ^a   Hirao, Yoshihiko ^a   Okajima, Eigoro ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

anti androgen withdrawal syndrome; prostate cancer; total androgen blockade

Indexed keywords

ANTIANDROGEN; CHLORMADINONE ACETATE; FLUTAMIDE; GONADORELIN AGONIST;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG WITHDRAWAL; HUMAN; MALE; PROSTATE CANCER; WITHDRAWAL SYNDROME;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; ANDROGEN ANTAGONISTS; FLUTAMIDE; GONADOTROPIN-RELEASING HORMONE; HUMANS; MALE; MIDDLE AGED; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 0030957119     PISSN: 00181994     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Labrie F, Belanger A, Simard J, et al.: Combination therapy for prostate cancer. endocrine and biologic basis of its choice as new standard first-line therapy. Cancer 71: 1059-1067, 1993
2. Huggins C and Hodges CV : Studies on prostatic cancer. I. the effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer Res 1 : 293-297, 1941
3. Borgmann V, Hardt W, Schmidt-Gollwitzer M, et al. : Sustained suppression of testosterone production by the luteinising-hormone releasing-hormone agonist buserelin in patients with advanced prostate carcinoma. Lancet 1: 1097-1099, 1982
4. Jacobo E, Schmidt JD, Weinstein SH, et al.: Comparison of flutamide (SCH-13521) and diethylstilbestrol in untreated advanced prostatic cancer. Urology 8: 231-233, 1976
5. Dupont A, Gomez J-L, Cusan L, et al.:Response to flutamide withdrawal in advanced prostate cancer in progression under combination therapy. J Urol 150 : 908-913, 1993
6. Jørgensen T, Tveter KJ and the members of the SPCG-2 group: Total androgen suppression: experience from the Scandinavian prostatic cancer group study No. 2. Eur Urol 24: 466-470, 1993
7. Monfette G, Dupont A and Labrie F: Temporary combination therapy with flutamide and tryptex as adjuvant to radical prostatectomy for the treatment of early stage prostate cancer. In: early stage prostate cancer : diagnosis and choice of therapy. Edt. by Labrie F, et al., pp.41-51, Elsevier Science Publishers B.V., New York, 1989
8. Labrie F, Dupont A, Gomez JL, et al. : Beneficial effect of combination therapy administered prior to radical prostatectomy. J Urol 149: 348A, 1993
9. Sassine AM and Schulman CC: Neoadjuvant hormonal deprivation before radical prostatectomy. Eur Urol 24 (Suppl): 46-50, 1993
10. Kelly WK and Scher HI : Prostate specific antigen decline after antiandrogen withdrawal: the flutamide withdrawal syndrome. J Urol 149: 607-609, 1993
11. Scher HI and Kelly WK: Flutamide withdrawal syndrdrome: its impact on clinical trials in hormone-refractory prostate cancer: J Clin Oncol 11: 1566-1572, 1993